• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchPanbela Therapeutics
    Picture of Panbela Therapeutics logo

    PBLA — Panbela Therapeutics News Story

    $0.000.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    • Market Cap
      $0.00m
    • Enterprise Value
      $6.26m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • PBLA Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    PBLA Dividends
    All News

    NASDAQ RESUMED AT 08:30 AM

    Picture of Panbela Therapeutics logoPanbela Therapeutics
    22/02/2022 13:30
    NASDAQ RESUMED  PBLA.O  AT 08:30 AM
    

    Recent news on Panbela Therapeutics

    See all news
    • Brief: Panbela Therapeutics Announces Third Independent Safety Review Of Phase 3 Aspire Clinical Trial DSMB Recommended Continuation With No Trial Modification

      24/06/2024 15:18
    • Brief: Nasdaq Notifies Panbela Therapeutics Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard

      07/03/2024 11:14
    • Brief: Panbela Announces Pricing of Approximately $9 Mln Public Offering

      29/01/2024 11:17
    • U.S. STOCKS ON THE MOVE-Fisker, Best Buy, NuStar Energy

      22/01/2024 18:28
    • Brief: Panbela Therapeutics Announces Exercise Of Warrants And Issuance Of New Warrants

      21/12/2023 15:03

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.